New thoughts on normal tension glaucoma

Optometry

Volumn 76, Issue 10, 2005, Pages 600-608

  Sowka, Joseph ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Antibodies; Autoimmune neuropathy; Autoimmunity; Collaborative Normal Tension Glaucoma Study; Heat shock protein; Normal tension glaucoma

Indexed keywords

EID: 27744437466     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2005.08.020     Document Type: Review

References (60)

1. Gutteridge IF. Normal tension glaucoma: diagnostic features and comparisons with primary open angle glaucoma. Clin Exp Optom 2000;83(3):161-72.
2. Sack J. The management of normal tension glaucoma. Clin Exp Optom 2000;83(3):185-9.
3. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-5.
4. Klein BE, Klein R, Sponsel WE, et al: Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992;99:1499-504.
5. Dielemans I, Vingerling JR, Wolfs RC, et al: The prevalence of primary open angle glaucoma in a population based study in the Netherlands. The Rotterdam Study. Ophthalmology 1994;101:1851-5.
6. Sommer A. Doyne lecture. Glaucoma: facts and fancies. Eye 1996;10:295-301.
7. Bonomi L, Marchini G, Marraffa M, et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Enga-Neumarkt Study. Ophthalmology 1998;105:209-15.
8. Cartwright MJ, Anderson DR. Correlation of asymmetric damage with asymmetric intraocular pressure in normal tension glaucoma. Arch Ophthalmol 1988;106:898-900.
9. Haefliger IO, Hitchings RA. Relationship between asymmetry of visual filed defects and intraocular pressure differences in an untreated normal tension glaucoma population. Acta Ophthalmol 1990;68:564-7.
10. Crichton A, Drance SM, Douglas GR, et al. Unequal intraocular pressure and its relation to asymmetric visual filed defects in low tension glaucoma. Ophthalmology 1989;96:1312-4.
11. Collaborative Normal Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-97.
12. Collaborative Normal Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal tension glaucoma. Am J Ophthalmol 1998;126:498-505.
13. Drance S, Anderson DR, Schulzer M, for The Collaborative Normal Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal tension glaucoma. Am J Ophthalmol 2001;131:699-708.
14. Caprioli J, Spaeth GL. Comparison of the optic nerve head in high- and low-tension glaucoma. Arch Ophthalmol 1985;103:1145-9.
15. Fazio P, Krupin T, Feitl ME, et al. Optic disc topography in patients with low tension and primary open angle glaucoma. Arch Ophthalmol 1990;108:705-8.
16. Caprioli J, Spaeth GL. Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas. Am J Ophthalmol 1984;97:730-7.
17. Hitchings RA, Anderton SA. A comparative study of visual field defects in low-tension glaucoma and chronic simple glaucoma. Br J Ophthalmol 1983;67:818-21.
18. Copt RP, Thomas R, Mermoud A. Corneal thickness in ocular hypertension, primary open angle glaucoma and normal tension glaucoma. Arch Ophthalmol 1999;117:14-16.
19. Morad Y, Sharon E, Hefetz L, et al. Corneal thickness and curvature in normal tension glaucoma. Am J Ophthalmol 1998;125:164-8.
20. Whitacre MM, Stein R. Sources of error with the Goldmann-type tonometers. Surv Ophthalmol 1993;38:1-30.
21. Jonas JB, Budde WB. Optic nerve head appearance in juvenile onset chronic high-pressure glaucoma and normal pressure glaucoma. Ophthalmology 2000;107:704-11.
22. Kitazawa Y, Shirato S, Yamamoto T. Optic disc hemorrhage in low-tension glaucoma. Ophthalmology 1986;93:853-7.
23. Jonas JB, Grundler AE, Gonzales-Cortes J. Pressure dependent neuroretinal rim loss in normal pressure glaucoma. Am J Ophthalmol 1998;125:137-44.
24. Healey PR, Mitchell P, Smith W, et al. Optic disc hemorrhages in a population with and without signs of glaucoma. Ophthalmology 1998;105:216-23.
25. Shihab ZM, Lee PF, Hay P. The significance of disc hemorrhage in open angle glaucoma. Ophthalmology 1982;89:211-3.
26. Susanna R, Drance SM, Douglas GR. The visual prognosis of the fellow eye in uniocular chronic open angle glaucoma. Br J Ophthalmol 1978;62:327-9.
27. Broadway DC, Drance SM. Glaucoma and vasospasm. Br J Ophthalmol 1998;82:862-70.
28. Drance SM, Schulzer M, Douglas GR, et al. Use of discrimination analysis of persons with glaucomatous visual field defects. Arch Ophthalmol 1978;96:1571-3.
29. Hayreh SS. The role of age and cardiovascular disease in glaucomatous optic neuropathy. Surv Ophthalmol 1999;43(Suppl 1):S27-S42.
30. Hayreh SS, Zimmerman MB, Podhajsky P, et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994;117:603-24.
31. Kaiser HJ, Flammer J, Graf T, et al. Systemic blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol 1993;231:677-80.
32. Meyer JH, Brandi-Dohrn J, Funk J. Twenty-four hour blood pressure monitoring in normal tension glaucoma. Br J Ophthalmol 1996; 80:864-7.
33. Hayreh SS, Podhajsky P, Zimmerman MB. Beta-blocker eye drops and nocturnal hypotension. Am J Ophthalmol 1999;128:301-9.
34. Gasser P, Flammer J. Influence of vasospasm on visual function. Doc Ophthalmol 1987;66:3-18.
35. Gasser P. Ocular vasospasm. A risk factor in the pathogenesis of low-tension glaucoma. Int Ophthalmol 1989;13:281-90.
36. Comoglu S, Yarangumeli A, Koz OG, et al. Glaucomatous visual field defects in patients with migraine. J Neurol 2003;250(2):201-6.
37. Riccadonna M, Covi G, Pancera P, et al. Autonomic system activity and 24-hour blood pressure variations in subjects with normal- and high-tension glaucoma. J Glaucoma 2003;12(2):156-63.
38. Cartwright MJ, Grajewski AL, Friedberg ML, et al. Immune-related disease and normal tension glaucoma. A case-control study. Arch Ophthalmol 1992;110:500-02.
39. Wax MB, Barrett DA, Pestronk A. Increased incidence of paraproteinemia and autoantibodies in patients with normal pressure glaucoma. Am J Ophthalmol 1994;117:561-78.
40. Ropper AH, Gorson KC. Current concepts: neuropathies associated with paraproteinemia. N Engl J Med 1998;338:1601-7.
41. Wax MB, Tezel G, Edward PD. Clinical and ocular histopathological findings in a patient with normal pressure glaucoma. Arch Ophthalmol 1998;116:993-1001.
42. Kremmer S, Kreuzfelder E, Klein R, et al. Antiphosphatidylserine antibodies are elevated in normal tension glaucoma. Clin Exp Immunol 2001;125:211-5.
43. Romano C, Li Z, Arendt A, et al. Epitope mapping of anti-rhodopsin antibodies from patients with normal pressure glaucoma. Invest Ophthalmol Vis Sci 1999;40:1275-80.
44. Romano C, Barrett DA, Li Z, et al. Anti-Rhodopsin antibodies in sera from patients with normal pressure glaucoma. Invest Ophthalmol Vis Sci 1995;36:1968-75.
45. Wax MB, Tezel G, Saito I, et al. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal pressure glaucoma. Am J Ophthalmol 1998;125:145-57.
46. Tezel G, Seigel GM, Wax MB. Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci 1998;39:2277-87.
47. Birnbaum G. Stress proteins: their role in the normal central nervous system and in disease states, especially in multiple sclerosis. Springer Semin Immunopathol 1995;17:107-18.
48. Rordorf G, Koroshetz WJ, Bonventre JV. Heat shock protects cultured neurons from glutamate toxicity. Neuron 1991;7:1043-51.
49. Lowenstein DH, Chan PH, Miles MF. The stress protein response in cultured neurons: characterization and evidence for a protective role in excitotoxicity. Neuron 1991;7:1053-60.
50. Alarcon-Segovia D, Ruiz-Arguelles A, Llorente L. Broken dogma: penetration of autoantibodies into living cells. Immunol Today 1996;17:163-4.
51. Fellman RL, Tezel G, Wax MB. Effects of methotrexate treatment on serum immunoreactivity of a patient with normal pressure glaucoma. Am J Ophthalmol 1999;127:724-5.
52. Tezel G, Edward DP, Wax MB. Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol 1999;117:917-24.
53. Buono LM, Foroozan R, Sergott RC, et al. Is normal tension glaucoma actually an unrecognized hereditary optic neuropathy? New evidence from genetic analysis. Curr Opin Ophthalmol 2002;13:362-70.
54. Aung T, Ocaka L, Ebenezer ND, et al. A major marker for normal tension glaucoma: association with polymorphisms in the OPA1 gene. Hum Genet 2002;110:52-6.
55. Aung T, Okada K, Poinoosawmy D, et al. The phenotype of normal tension glaucoma patients with and without OPA 1 polymorphisms. Br J Ophthalmol 2003;87(2):149-52.
56. Drance SM, Crichton A, Mills RP. Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma. Am J Ophthalmol 1998;125(5):585-92.
57. Greve EL, Rulo AH, Drance SM, et al. Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: a review of short-term studies with three dose regimens of latanoprost treatment. Surv Ophthalmol 1998;41(Suppl 2):S89-92.
58. McKibbin M, Menage MJ. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. Eye 1999;13(Pt 1):31-4.
59. Liu CJ, Ko YC, Cheng CY, et al. Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients. Ophthalmology 2002;109(12):2241-7.
60. Liu CJ, Ko YC, Cheng CY, et al. Effect of latanoprost 0.005% and brimonidine tartrate 0.2% on pulsatile ocular blood flow in normal tension glaucoma. Br J Ophthalmol 2002;86(11):1236-9.